Design, facile synthesis, antibacterial activity and structure-activity relationship of novel di- and tri-substituted 1,3,5-triazines

Letters in Drug Design and Discovery

Volumn 9, Issue 3, 2012, Pages 329-335

  Ghosh, Surajit Kumar ^a   Saha, Ashmita ^a   Hazarika, Bornali ^a   Singh, Udaya Pratap ^b   Bhat, Hans Raj ^b   Gahtori, Prashant ^a  

^a DIBRUGARH UNIVERSITY   (India)

^b SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE   (India)

Author keywords

1,3,5 triazine; Antibacterial; FTIR spectrum; Nucleophilic substitution; Synthesis

Indexed keywords

CIPROFLOXACIN; TRIAZINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 84858207209     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018012799129846     Document Type: Article

References (17)

1. st century. Curr. Opin. Microbiol., 2001, 4(6), 491-492.
2. Finch, R.G. Antibiotic resistance: a view from the prescriber. Nat. Rev. Microbiol., 2004, 2(12), 989-994. (Pubitemid 39562538)
3. Bongarzone, S.; Bolognesi, M.L. The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases. Expert Opin.Drug Discovery., 2011, 6(3), 251-268.
4. Guidos, R.J. Combating Antimicrobial Resistance: Policy Recommendations to Save Lives. Clin. Infect. Dis., 2011, 52(5), 397-428.
5. Srinivas, K.; Srinivas, U.; Rao, V.J.; Bhanuprakash, K.; Kishore, K.H.; Murty, U.S.N. Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines. Bioorg. Med. Chem. Lett., 2005, 15(4), 1121-1123. (Pubitemid 40458659)
6. Singh, U.P.; Singh, R. K.; Bhat, H. R.; Subhashchandra, Y. P.; Kumar, V.; Kumawat, M. K.; Gahtori, P. Synthesis and Antibacterial Evaluation of Series of Novel Tri Substituted-s- Triazine Derivatives. Med. Chem. Res., 2011, 20(9), 1603-1610.
7. Al-Khamees, H.Synthesis of new derivatives of 1, 3, 5-Hexahydros- triazine as potential anticancer agents. Arch. Pharmacal Res., 1990, 13(1), 19-23. (Pubitemid 20262705)
8. Bekircan, O.; Küxük, M.; Kahveci, B.; Kolayl, S. Convenient Synthesis of Fused Heterocyclic 1,3,5-Triazines from Some N-Acyl Imidates and Heterocyclic Amines as Anticancer and Antioxidant Agents. Arch. Pharm., 2005, 338(8), 365-372. (Pubitemid 41169996)
9. Bhat, H.R.; Singh, U.P.; Yadav, P.S.; Kumar, V.; Gahtori, P.; Das, A.; Chetia, D.; Prakash, A.; Mahanta, J. Synthesis, characterization and antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Arabian J. Chem., 2011, In press; DOI: 10.1016/j.arabjc.2011.07.001
10. Agarwal, A.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Syntheses of 2,4,6-trisubstituted triazines as antimalarial agents. Bioorg. Med. Chem. Lett., 2005, 15(3), 531-533. (Pubitemid 40143120)
11. Garaj, V.; Puccetti, L.;Fasolis, G.; Winum, J.; Montero, J.; Scozzafava, A.; Vullo, D.; Innocenti, A.; Supuran. C.T. Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5- triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Bioorg. Med. Chem. Lett., 2005, 15(12), 3102-3108.
12. Golankiewicz, B.; Januszczyk, P.; Ikeda, S.; Balzarini, J.; De, Clercq, E. Synthesis and antiviral evaluation of imidazo[1,5-a]- 1,3,5-triazine (5,8-diaza-7,9-dideazapurine)derivatives. J Med Chem., 1995, 38(18), 3558-3565.
13. Junejo, J.A.; Ghosh, S.K.; Shaikh, M.; Gahtori, P.; Singh U.P. Facile synthesis, antibacterial activity and molecular properties prediction of some new 1,3-dihydroimidazol-2-thione derivatives. Lett. Drug Des. Discov., 2011, 8(8), 763-768.
14. Sangshetti, J.N.; Shinde, D.B. One pot synthesis and SAR of some novel 3-substituted 5,6-diphenyl- 1,2,4-triazines as antifungal agents. Bioorg. Med. Chem. Lett., 2010, 20(2), 742-745.
15. Patel, R.V.; Patel, A.B.; Kumari, P.; Chikahalia, K.H. Synthesis of novel 3-(5-sulfanyl-1,3,4-oxadiazol-2-yl)-2H-chromen-2-one condensed s-triazinyl piperazines and and piperidines as antimicrobial agents. Med. Chem. Res., 2011, Online First, DOI: 10.1007/s00044-011-9842-7.
16. Perez, C., Pauli, M., Bazerque, P. An antibiotic assay by the well agar method. Acta Biol. Med. Exp., 1990, 15, 113-115.
17. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E.DEF 2.1, August 2000: Determination of antimicrobial susceptibility test breakpoints. Clin. Microbiol. Infect. 2000, 6(9), 509-515.